Christian Reinhardt
|
Prof. Dr. med. Hans Christian Reinhardt University Hospital Essen Dept. of Hematology & Stem Cell Transplantation Hufelandstr. 55, 45147, Essen, Germany |
Education
1996-2003 Medical school, University of Hamburg, Germany; Humboldt University, Berlin, Germany; University of Freiburg, Germany.
1999-2003 MD thesis, Dept. of Internal Medicine, Division 4, University of Freiburg. Entitled: Expression of functional CC- and CXC chemokine receptors in podocytes. Advisor: Prof. Dr. H. Pavenstädt (Grade: Summa cum laude)
Professional Experience
01.07.2022 Co-Speaker NRW Network CANTAR - Cancer Targeting
01.01.2022 Vice-Speaker Collaborative Research Center "Mechanisms of Transformation and Resistance in Diffuse Large B Cell Lymphoma" (SFB-1530)
01.07.2020 Co-founder of CDL Therapeutics GmbH
since 2020 Professor for Internal Medicine, Hematology and Stem Cell Transplantation (W3), University Hospital Essen
since 2020 Director Dept. of Hematology and Stem Cell Transplantation, University Hospital Essen
since 2020 Elected member of the board of the Competence Network Malignant Lymphoma
since 2019 Elected member of the certification committee of the German Cancer Society (Zertifizierungskommission der Deutschen Krebsgesellschaft) for hematological malignancies
since 2019 Elected Vice-Speaker of the network of Mildred Scheel Schools of Oncology (Hamburg, Würzburg, Dresden, Frankfurt, Köln-Bonn)
since 2019 Co-Speaker Collaborative Research Center "Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer" (SFB-1399)
2018 - 2020 Speaker of the Mildred Scheel School of Oncology Cologne-Bonn: Cancer- and Immuno-genomics
since 2018 Member of the Expert Pool of the National Committee on Animal Welfare (TierSchG) within the Federal Institute of Risk Assessment (Bundesinstitut für Risikobewertung)
2017 - 2020 Speaker of the Else Kröner Research College: Clonal evolution in cancer
2015 - 2020 Attending physician at the Dept. I of Internal Medicine, University Hospital Cologne
2015 Board exam (certified in general internal medicine and hematology and medical oncology)
2015 - 2020 Elected member of the executive board of the Center for Molecular Medicine Cologne
2013 - 2020 Head of the Clinical Research Unit-286 “Exploiting defects in the DNA damage response for the treatment of CLL” (KFO-286)
2012-2015 Elected member of the steering committee of the Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC)
2012 - 2020 Excellence Cluster CECAD
2012 - 2020 Professor for Clinical and Molecular Oncology (W2), University Hospital Cologne
2009- 2015 Emmy-Noether fellowship at the Dept. I of Internal Medicine, University Hospital Cologne
2008- Habilitation for Molecular Medicine, Medical Faculty, University of Cologne
2004 - 2009- Postdoctoral Associate, MIT, Department of Biology, Koch Institute, Advisors: M.B. Yaffe, and T. Jacks
2004 Postdoctoral Research Fellow, University of Münster, Germany, Advisor: H. Pavenstädt.
2003 Postdoctoral Research Fellow University of Freiburg, Germany, Advisor: G. Walz and T. Benzing
Awards
2021: Astra-Zeneca Scholar Award in Hematology Research
2017: Gilead Research Award Oncology
2016: Theodor Frerichs Award of the German Society for Internal Medicine
2012: GlaxoSmithKline Research Award
2011: Vincenz Czerny Award of the German Society for Hematology and Oncology
2011: W2 Lichtenberg Professorship of the VolkswagenStiftung
2011: CESAR Research Award of the Central European Society for Anticancer Drug Research
2011: Johann-Georg-Zimmermann Award for Cancer Research
2010: Young Leaders in Science Award of the Schering Stiftung
2009: Startup grant from the Ministerium für Innovation, Wissenschaft, Forschung und Technologie des Landes NRW
2009: NIH/NCI K99/R00 PI award (relinquished due to return to Germany)
2007: MIT-Koch Award
2004: Young investigator award of the Deutsche Nierenstiftung